These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21668904)

  • 21. Direct and indirect estimates of HIV-1 incidence in a high-prevalence population.
    Cleghorn FR; Jack N; Murphy JR; Edwards J; Mahabir B; Paul R; O'Brien T; Greenberg M; Weinhold K; Bartholomew C; Brookmeyer R; Blattner WA
    Am J Epidemiol; 1998 May; 147(9):834-9. PubMed ID: 9583713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes.
    Janssen RS; Satten GA; Stramer SL; Rawal BD; O'Brien TR; Weiblen BJ; Hecht FM; Jack N; Cleghorn FR; Kahn JO; Chesney MA; Busch MP
    JAMA; 1998 Jul; 280(1):42-8. PubMed ID: 9660362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new method for estimating HIV incidence from a single cross-sectional survey.
    Fellows IE; Shiraishi RW; Cherutich P; Achia T; Young PW; Kim AA
    PLoS One; 2020; 15(8):e0237221. PubMed ID: 32785257
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of biomarker based incidence estimators.
    McWalter TA; Welte A
    PLoS One; 2009 Oct; 4(10):e7368. PubMed ID: 19809505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of current human immunodeficiency virus incidence rates from a cross-sectional survey using early diagnostic tests.
    Brookmeyer R; Quinn TC
    Am J Epidemiol; 1995 Jan; 141(2):166-72. PubMed ID: 7817972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of prospective and cross-sectional measures of HIV type 1 incidence in a higher-risk cohort in Ho Chi Minh City, Vietnam.
    Sexton CJ; Costenbader EC; Vinh DT; Chen PL; Hoang TV; Lan NT; Feldblum P; Kim A; Giang le T
    AIDS Res Hum Retroviruses; 2012 Aug; 28(8):866-73. PubMed ID: 21936716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On comparison of mixture models for closed population capture-recapture studies.
    Xuan Mao C; You N
    Biometrics; 2009 Jun; 65(2):547-53. PubMed ID: 18510651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimation of incidence of HIV infection using cross-sectional marker surveys.
    Statten GA; Longini IM
    Biometrics; 1994 Sep; 50(3):675-88. PubMed ID: 7981394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating survival and association in a semicompeting risks model.
    Lakhal L; Rivest LP; Abdous B
    Biometrics; 2008 Mar; 64(1):180-8. PubMed ID: 17645782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On estimation in relative survival.
    Perme MP; Stare J; Estève J
    Biometrics; 2012 Mar; 68(1):113-20. PubMed ID: 21689081
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isotonized CDF estimation from judgment poststratification data with empty strata.
    Wang X; Wang K; Lim J
    Biometrics; 2012 Mar; 68(1):194-202. PubMed ID: 21838805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Competing risks analysis of correlated failure time data.
    Chen BE; Kramer JL; Greene MH; Rosenberg PS
    Biometrics; 2008 Mar; 64(1):172-9. PubMed ID: 17680835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV incidence estimation using the BED capture enzyme immunoassay: systematic review and sensitivity analysis.
    Bärnighausen T; McWalter TA; Rosner Z; Newell ML; Welte A
    Epidemiology; 2010 Sep; 21(5):685-97. PubMed ID: 20699682
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimating HIV hazard rates from cross-sectional HIV prevalence data.
    Wong KF; Tsai WY; Kuhn L
    Stat Med; 2006 Jul; 25(14):2441-9. PubMed ID: 16220498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-sectional HIV incidence estimation in an evolving epidemic.
    Morrison D; Laeyendecker O; Brookmeyer R
    Stat Med; 2019 Aug; 38(19):3614-3627. PubMed ID: 31115081
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection.
    Laeyendecker O; Konikoff J; Morrison DE; Brookmeyer R; Wang J; Celum C; Morrison CS; Abdool Karim Q; Pettifor AE; Eshleman SH
    J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29489059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating biomarker-based HIV incidence using prevalence data in high risk groups with missing outcomes.
    Chu H; Cole SR
    Biom J; 2006 Aug; 48(5):772-9. PubMed ID: 17094342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The AIDS epidemic in India: a new method for estimating current human immunodeficiency virus (HIV) incidence rates.
    Brookmeyer R; Quinn T; Shepherd M; Mehendale S; Rodrigues J; Bollinger R
    Am J Epidemiol; 1995 Oct; 142(7):709-13. PubMed ID: 7572940
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIITE: HIV-1 incidence and infection time estimator.
    Park SY; Love TMT; Kapoor S; Lee HY
    Bioinformatics; 2018 Jun; 34(12):2046-2052. PubMed ID: 29438560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimation of covariate-specific time-dependent ROC curves in the presence of missing biomarkers.
    Li S; Ning Y
    Biometrics; 2015 Sep; 71(3):666-76. PubMed ID: 25891918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.